Using Biomarkers to Support a Precision Medicine Approach to Antifibrotic Drug Development
- Demonstrating target engagement early in your program
- Exploring the impact of engaging your target in downstream biomarkers
- Applying the observed effect of downstream biomarkers to select the patient population for late-stage clinical development